P

Philip E. Brandish

Merck & Co., Inc., Rahway, NJ, USA (United States)

ORCID: 0000-0002-5591-8973

100 papers and 2.8k citations.

PubIndex Score98Top 2% · mid-careerHow it's scored

100Publications

2.8kTotal Citations

First senior author: 2020

Top publicationsby citations

Discovery of Pyrophosphate Diesters as Tunable, Soluble, and Bioorthogonal Linkers for Site-Specific Antibody–Drug Conjugates

Jeffrey C. Kern, R. M. Garbaccio, Isabel Figueroa et al.|Journal of the American Chemical Society|2016

Cited by 141

Novel Phosphate Modified Cathepsin B Linkers: Improving Aqueous Solubility and Enhancing Payload Scope of ADCs

Jeffrey C. Kern, R. M. Garbaccio, Deborah Dooney et al.|Bioconjugate Chemistry|2016

Cited by 94

Development of Anti-CD74 Antibody–Drug Conjugates to Target Glucocorticoids to Immune Cells

Philip E. Brandish, Mark Zielstorff, Anthony Palmieri et al.|Bioconjugate Chemistry|2018

Cited by 58

Indexing the rest of 100 publications…